世界の除細動器市場は2021年の114億ドルから2026年までに182億ドルに達し、CAGRは9.7％と予想されます。 市場の成長を促す主な要因としては、主に対象疾患の有病率の上昇、パブリックアクセス除細動器の提供への注目の高まり、除細動器に関するトレーニングと意識向上プログラムが挙げられます。さらに、新興市場とS-ICDおよびMRI互換ICDおよびCRT-Dの開発によって、除細動器市場のプレーヤーの成長機会が生まれる可能性があります。ただし、植込み型および自動体外式除細動器の使用、頻繁な製品のリコール、および開発途上国での突然の心停止についての認識の欠如に関連する問題が、予測期間中の除細動器市場の成長を妨げると予想されます。先進国における限定的な保険適応、特に発展途上国や未開発国におけるインフラの不備といった要因も、抑制要因になります。
COVID-19のパンデミックは、2020年の経済に悪影響を及ぼし、世界中の臨床医療提供者と患者にとってさまざまな問題が露呈しました。ロジスティクスの問題、この疾患に罹った患者の管理、併存疾患や既存疾患があるの患者の優先順位付け、さらに公的および病院の最前線の労働者をCOVID-19から保護することは、世界中の医療システムが直面する主要な課題です。
パンデミックはさらに、病院、特に小規模病院の購入能力にも影響を与え、その結果、供給取引のキャンセルや延期が続き、除細動器市場の全ての主要プレーヤーの全体的な収益に影響を与えました。また、封鎖によって、多くの人々が職と生計を失い、それが患者の消費行動に大きな影響を及ぼしました。
多くのCOVID患者で不整脈が見られましたが、院内除細動器施設が患者の命を救うのに役立ちました。ウイルスの発生によって、患者の重症度に応じて多くの外科手術がキャンセルまたは延期されたことから、企業は損失を被りました。
COVID-19はまた、ほとんどの国の政府が発出した厳格なロックダウンを主な要因として、バリューチェーンのさまざまな段階に影響を与えました。国が課した新しいパッケージングプロトコルとロックダウン措置のために、製品やサービスの提供にかかる時間も影響を受けました。これら全ての要因が、除細動器市場の製造とサプライチェーンに悪影響を及ぼしました。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 KEY MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 25)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET DATA VALIDATION AND TRIANGULATION
2.4 KEY RESEARCH ASSUMPTIONS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 COVID-19 HEALTH ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
3 EXECUTIVE SUMMARY (Page No. - 36)
4 PREMIUM INSIGHTS (Page No. - 40)
4.1 DEFIBRILLATORS MARKET OVERVIEW
4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020 (USD MILLION)
4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
5 MARKET OVERVIEW (Page No. - 43)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of target diseases
5.2.1.2 Growing focus on providing public-access defibrillators
5.2.1.3 Training & awareness programs on defibrillators
5.2.2 RESTRAINTS
5.2.2.1 Issues related to the use of implantable and automated external defibrillators
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
5.2.4 CHALLENGES
5.2.4.1 Frequent product recalls
5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations
5.3 INDUSTRY TRENDS
5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS
5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS
5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS
5.4 PRICING ANALYSIS
5.5 REGULATORY ANALYSIS
5.5.1 NORTH AMERICA
5.5.1.1 US
5.5.1.2 Canada
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.3.1 Japan
5.5.3.2 China
5.5.3.3 India
5.6 VALUE CHAIN ANALYSIS
5.6.1 RESEARCH & DEVELOPMENT
5.6.2 MANUFACTURING & ASSEMBLY
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.7 ECOSYSTEM LANDSCAPE
5.8 REIMBURSEMENT SCENARIO
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT FROM NEW ENTRANTS
5.9.2 THREAT FROM SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET
5.11 PATENT ANALYSIS
5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS
6 DEFIBRILLATORS MARKET, BY TYPE (Page No. - 64)
6.1 INTRODUCTION
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators
6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth
6.2.1.2 Dual-chamber ICDs
6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks—a key factor driving market growth
6.2.1.3 Single-chamber ICDs
6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks—a key factor limiting market growth
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market
6.3 EXTERNAL DEFIBRILLATORS
6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.2.1 Increasing installation of these devices in public places to drive market growth
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE (Page No. - 80)
7.1 INTRODUCTION
7.2 ADULT PATIENTS
7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS
7.3 PEDIATRIC PATIENTS
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH
8 DEFIBRILLATORS MARKET, BY END USER (Page No. - 84)
8.1 INTRODUCTION
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS—A KEY FACTOR DRIVING MARKET GROWTH
8.3 PREHOSPITAL CARE SETTINGS
8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH
8.4 PUBLIC-ACCESS MARKETS
8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS
8.5 ALTERNATE CARE FACILITIES
8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH
8.6 HOME CARE SETTINGS
8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS—A KEY FACTOR DRIVING MARKET GROWTH
8.7 OTHER END USERS
9 DEFIBRILLATORS MARKET, BY REGION (Page No. - 91)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.1.1 High adoption rate of AEDs in the country to drive market growth
9.2.2 CANADA
9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada
9.3 EUROPE
9.3.1 GERMANY
9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany
9.3.2 UK
9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth
9.3.3 FRANCE
9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population—a key driver for market growth in France
9.3.4 ITALY
9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy
9.3.5 SPAIN
9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth
9.4.2 CHINA
9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth
9.4.3 INDIA
9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth
9.4.4 AUSTRALIA
9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth
9.4.5 SOUTH KOREA
9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea
9.4.6 REST OF ASIA PACIFIC (ROAPAC)
9.5 LATIN AMERICA
9.5.1 BRAZIL
9.5.1.1 Large obese population in the country results in an increased demand for defibrillators
9.5.2 MEXICO
9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico
9.5.3 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE (Page No. - 143)
10.1 INTRODUCTION
10.2 REVENUE SHARE ANALYSIS
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020)
10.4.1 TERMINOLOGY/NOMENCLATURE
10.4.1.1 Stars
10.4.1.2 Emerging leaders
10.4.1.3 Pervasive players
10.4.1.4 Participants
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
10.6 COMPETITIVE BENCHMARKING
10.7 COMPETITIVE SCENARIO (2018-2021)
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 157)
11.1 KEY PLAYERS
11.1.1 MEDTRONIC
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.4 MnM view
11.1.2 STRYKER CORPORATION
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.3 KONINKLIJKE PHILIPS N.V.
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.4 MnM view
11.1.4 ASAHI KASEI CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 Recent developments
11.1.5 BOSTON SCIENTIFIC CORPORATION
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.4 MnM view
11.1.6 ABBOTT
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.6.3 Recent developments
11.1.7 MICROPORT
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.7.3 Recent developments
11.1.8 NIHON KOHDEN CORPORATION
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 BIOTRONIK
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.9.3 Recent developments
11.1.10 CU MEDICAL SYSTEMS INC.
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.11 METSIS MEDIKAL
11.1.11.1 Business overview
11.1.11.2 Products offered
11.1.12 MEDIANA CO. LTD.
11.1.12.1 Business overview
11.1.12.2 Products offered
11.1.12.3 Recent developments
11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED
11.1.13.1 Business overview
11.1.13.2 Products offered
11.1.13.3 Recent developments
11.1.14 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS
11.1.14.1 Business overview
11.1.14.2 Products offered
11.1.15 SCHILLER AG
11.1.15.1 Business overview
11.1.15.2 Products offered
11.1.15.3 Recent developments
11.2 OTHER PLAYERS
11.2.1 BPL MEDICAL TECHNOLOGIES
11.2.1.1 Business overview
11.2.1.2 Products offered
11.2.2 METRAX GMBH (PRIMEDIC)
11.2.2.1 Business overview
11.2.2.2 Products offered
11.2.3 MS WESTFALIA GMBH
11.2.3.1 Business overview
11.2.3.2 Products offered
11.2.4 BEXEN CARDIO
11.2.4.1 Business overview
11.2.4.2 Products offered
11.2.4.3 Recent developments
11.2.5 AXION MEDICAL EQUIPMENT LTD.
11.2.5.1 Business overview
11.2.5.2 Products offered
11.2.6 ELEMENT SCIENCE INC.
11.2.6.1 Business overview
11.2.6.2 Products offered
11.2.7 AVIVE SOLUTIONS INC.
11.2.7.1 Business overview
11.2.7.2 Products offered
11.2.8 JEEVTRONICS PVT. LTD.
11.2.8.1 Business overview
11.2.8.2 Products offered
11.2.9 HEARTHERO INC.
11.2.9.1 Business overview
11.2.9.2 Products offered
11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
11.2.10.1 Business overview
11.2.10.2 Products offered
12 APPENDIX (Page No. - 209)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
LIST OF TABLES (174 TABLES)
TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET
TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018-2021
TABLE 3 PRICING ANALYSIS: DEFIBRILLATORS MARKET, 2021 (USD )
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US
TABLE 11 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
TABLE 13 DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 15 DEFIBRILLATORS MARKET, END USER, 2018-2026 (USD MILLION)
TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 27 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 37 DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018-2026 (USD MILLION)
TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018-2026 (USD MILLION)
TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2018-2026 (USD MILLION)
TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018-2026 (USD MILLION)
TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 52 US: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 56 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2017-2025 (USD MILLION)
TABLE 60 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 64 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 67 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 71 UK: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 74 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 75 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 79 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 83 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 87 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 98 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 102 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 106 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 110 AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 114 SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 122 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 129 BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 133 MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-202 (USD MILLION)
TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018-2026 (USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2018-2026 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018-2026 (USD MILLION)
TABLE 147 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET
TABLE 148 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET
TABLE 149 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATORS MARKET
TABLE 150 MEDTRONIC: BUSINESS OVERVIEW
TABLE 151 STRYKER CORPORATION: BUSINESS OVERVIEW
TABLE 152 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
TABLE 153 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
TABLE 154 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
TABLE 155 ABBOTT: BUSINESS OVERVIEW
TABLE 156 MICROPORT: BUSINESS OVERVIEW
TABLE 157 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
TABLE 158 BIOTRONIK: BUSINESS OVERVIEW
TABLE 159 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW
TABLE 160 METSIS MEDIKAL: BUSINESS OVERVIEW
TABLE 161 MEDIANA CO. LTD.: BUSINESS OVERVIEW
TABLE 162 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
TABLE 163 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW
TABLE 164 SCHILLER AG: BUSINESS OVERVIEW
TABLE 165 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
TABLE 166 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW
TABLE 167 MS WESTFALIA GMBH: BUSINESS OVERVIEW
TABLE 168 BEXEN CARDIO: BUSINESS OVERVIEW
TABLE 169 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW
TABLE 170 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW
TABLE 171 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW
TABLE 172 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW
TABLE 173 HEARTHERO INC.: BUSINESS OVERVIEW
TABLE 174 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
LIST OF FIGURES (39 FIGURES)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 REVENUE MAPPING-BASED MARKET ESTIMATION
FIGURE 3 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 4 DATA TRIANGULATION METHODOLOGY
FIGURE 5 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 6 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021-2022)
FIGURE 7 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 8 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026
FIGURE 9 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET
FIGURE 11 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
FIGURE 12 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020
FIGURE 13 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026
FIGURE 14 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS
FIGURE 15 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (THOUSAND)
FIGURE 17 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS
FIGURE 18 PATENTS GRANTED FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
FIGURE 19 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021)
FIGURE 20 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION (JANUARY 2011 TO SEPTEMBER 2021)
FIGURE 21 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET
FIGURE 22 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
FIGURE 23 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
FIGURE 24 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2018-2021
FIGURE 25 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET
FIGURE 26 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2020
FIGURE 27 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
FIGURE 28 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS)
FIGURE 29 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
FIGURE 30 STRYKER CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2020)
FIGURE 35 MICROPORT: COMPANY SNAPSHOT (2020)
FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 37 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020)
FIGURE 38 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020)
FIGURE 39 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020)
